BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8804803)

  • 21. Methotrexate and misoprostol to terminate early pregnancy.
    Hausknecht RU
    N Engl J Med; 1995 Aug; 333(9):537-40. PubMed ID: 7623901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abortion induced with methotrexate and misoprostol: a comparison of various protocols.
    Wiebe ER
    Contraception; 1997 Mar; 55(3):159-63. PubMed ID: 9115004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial.
    Creinin MD; Vittinghoff E
    JAMA; 1994 Oct; 272(15):1190-5. PubMed ID: 7523739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women.
    Beckman LJ; Harvey SM
    Womens Health Issues; 1997; 7(4):253-62. PubMed ID: 9283280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion.
    Creinin MD; Shulman T
    Contraception; 1997 Sep; 56(3):165-8. PubMed ID: 9347207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical abortion with oral methotrexate and vaginal misoprostol.
    Creinin MD; Vittinghoff E; Schaff E; Klaisle C; Darney PD; Dean C
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):611-6. PubMed ID: 9380325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol.
    Wiebe ER
    Contraception; 1997 Feb; 55(2):67-71. PubMed ID: 9071514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early abortion. Update and implications for midwifery practice.
    Narrigan D
    J Nurse Midwifery; 1998; 43(6):492-501. PubMed ID: 9871382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal misoprostol for late first trimester abortion.
    Carbonell Esteve JL; Varela L; Velazco A; Cabezas E; Tanda R; Sánchez C
    Contraception; 1998 May; 57(5):329-33. PubMed ID: 9673840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 25 mg or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion: a randomized trial.
    Carbonell Esteve JL; Varela L; Velazco A; Tanda R; Sánchez C
    Gynecol Obstet Invest; 1999; 47(3):182-7. PubMed ID: 10087413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination.
    Jain JK; Meckstroth KR; Park M; Mishell DR
    Contraception; 1999 Dec; 60(6):353-6. PubMed ID: 10715370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.